TSHA
TSHA
NASDAQ · Biotechnology

Taysha Gene Therapies Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$4.43
+0.30 (+7.26%)
As of Mar 25, 2:00 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 19 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +1,273.8% upside
Low Target $45.99
Average Target $60.86
High Target $68.15
Current Price $4.43
Current
$4.43
Target
$60.86
$45.99 $60.86 avg $68.15
Scenario Analysis
Bear Case
$45.99
938.1%
Low target
Base Case
$60.86
+1,273.8%
Avg target
Bull Case
$68.15
+1,438.4%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$6.02
-26.4% from high
52-Week Low
$1.05
+321.9% from low
Target vs 52W High
$60.86
+911.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%